Alopecia refers to loss of hair from parts of the head or body. Sedentary lifestyle, and unhealthy diets is leading loss of hair among masses. Hormonal miss proportion and aging contribute to rising cases of hair loss. Overall rise in geriatric population and rising awareness and preference for surgical hair transplants and other such treatments is also a positive influence for the global market in the forecast period.
The market research study on “Alopecia Market (By Disease Type: Alopecia Areata, Androgenetic Alopecia; By End Users: Homecare Settings, Dermatology Clinics; By Distribution Channel: Prescriptions, OTC) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026” offers a detailed outlook, strategic recommendations, and insightful viewpoints on the global Alopecia market. The report also analyzes the key players operating in Alopecia market and identifies the key strategies deployed by them along with the market share of leading players.
The global Alopecia market is segmented as below:
Alopecia Market by Disease Type
Alopecia Market by End Users
Alopecia Market by Distribution Channel
Alopecia Market by Geography
The global alopecia market is expected to grow at a CAGR of around 5.0%. In 2018, the market was valued at 8.44 billion USD. Product developments are expected to drive the market growth in the near future. Recent product development such as introduction of rapidly acting JAK drugs approved by the U.S. Food and Drug Administration (FDA), developments of methods to stimulate hair growth using human pluripotent stem cells, development of PRP treatment, introduction of a new drug SM04554 which Specifically which stimulate hair growth in men are driving factors. Technological advancements and product like Hairmax Laser Comb, Follinex Massager Comb, Lifemax Infrared Hair Brush and Hair Growth Renewing lasers are some of the products built on advanced technology. The launch of new drugs and the treatment success rate and the clinical outcomes are some of the biggest drives.
The global alopecia market is segmented on the basis of types, end users, and distribution channel. On the basis of disease type, the global market is segmented into alopecia areata, and androgenetic alopecia. On the basis of end users, the market is segmented into homecare settings, dermatology clinics, and others. And on the basis of distribution channel, the market is categorized into prescriptions and OTC.
Geographical the Global Alopecia market is divided into five regions: North America, Europe, Asia Pacific, Latin America, Middle East and Africa.
North America leads the market with and is expected to grow lucratively over the forecast period. Presence of technologically advanced healthcare infrastructure, High disposable income and availability of novel therapeutic options affecting to the treatment are some of the factors contributing to the high market share of North America.
Europe is expected to dominate in the near future owing to outburst of middle-aged population. Asia Pacific has also witnessed growth owning to a large population suffering from Alopecia and rising awareness affecting to the available therapeutic options are the key drivers. Latin America, Middle East and Africa are expected to have a sluggish growth. However, these region are expecting a healthy market growth owing to the huge opportunity for the market growth.
Some of the leading companies operating in the global alopecia market include Cipla,Dr. Reddy’s Laboratories Ltd, Merck & Co.,Viviscal, Regaine, Ranbaxy Laboratories Ltd, Kirkland Signature, Lexington International LLC, Vitabiotics, Alpecin - Dr. Kurt Wolff GmbH & Co, Johnson and Johnson, GlaxoSmithKline PLC
The global cancer biomarkers market size is expected to reach around US$ 29.8 Bn by 2026 and will grow at noteworthy CAGR of around 11.9% over the forecast period 2019 to 2026. Cancer biomarker is a substance that helps to indicate the presence of cancer in the body. This substance may be a molecule secreted by a tumor or specific response of the body to a tumor. Genetic, proteomic
The global 4D printing in healthcare market size is expected to reach around US$ 34.1 Mn by 2026 growing at a CAGR of around 29.6% over the forecast period 2019 to 2026. 4D printing is the latest technology in healthcare that is going to revolutionize the artificial organs and prosthetics industry. 4D printing is a product of collaboration work between MIT’s Lab and Stratasys. 4D printing is evolved 3D p
The global healthcare consulting services market size is expected to reach around US$ 22.8 Bn by 2026 and growing at a CAGR of around 9.8% over the forecast period 2019 to 2026. Healthcare consultancy service providers advice life science companies, government bodies, hospitals, insurance companies, and research institutes about business strategies. Digital consulting, financial consulting, operations consulta
The global healthcare analytics market size is expected to hit around US$ 52.2 Bn by 2026 and will grow at a CAGR of around 23.4% over the forecast period 2019 to 2026. Healthcare analytics are the solutions that involve all the healthcare analysis activities by using data from the key areas of the healthcare: pharmaceutical and R&D data, patient behaviors data, clinical data, and claims & cost data. H
The global electronic health record market size is expected to reach over US$ 30 Bn by 2026 and is anticipated to grow at a CAGR over 5.5% in terms of revenue during the forecasting period from 2019 to 2026. EMRs refer to both individual patient documents and usually to systems that retain patient documents and serve as data entry interfaces and test ordering, other processes and p
The global medical electronics market value is expected to surpass US$ 122 Bn by 2026 and is anticipated to grow at a CAGR of around 6% in terms of revenue during the forecast period from 2019 to 2026. Medical electronics refer to a certain category of electronic instruments and equipment specifically used for medical application such as diagnosis, treatment, study, control of anes